Literature DB >> 25479940

Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa.

Takatsugu Ishimoto1, Daisuke Izumi, Masayuki Watanabe, Naoya Yoshida, Kosei Hidaka, Keisuke Miyake, Hidetaka Sugihara, Hiroshi Sawayama, Yu Imamura, Masaaki Iwatsuki, Shiro Iwagami, Yoshifumi Baba, Hasita Horlad, Yoshihiro Komohara, Motohiro Takeya, Hideo Baba.   

Abstract

BACKGROUND: Infection with Helicobacter pylori is the main risk factor for development of gastric cancer. CD44 overexpression, especially that of variant 9 (CD44v9), has also been implicated in the local inflammatory response and metaplasia-carcinoma sequence in human stomach. We recently identified miR-328 as one of the microRNAs targeting CD44 in gastric cancer. The aim of the current study was to determine the relationship between miR-328 and CD44v9 expression in H. pylori-infected gastric mucosa during the development of preneoplastic lesions.
METHODS: Immunohistochemical staining of myeloperoxidase and CD44v9 was performed using paraffin-embedded tissue sections obtained from 54 patients who underwent gastric resection without preoperative treatment. The levels of miR-328 expression in the gastric mucosa were measured in the same patients using quantitative reverse transcription polymerase chain reaction.
RESULTS: Both infiltration of myeloperoxidase-positive inflammatory cells and expression of proinflammatory cytokines closely correlated with H. pylori infection in the cancer-afflicted gastric mucosa. High CD44v9 expression levels, identified in the gastric mucosa in 61 % of samples (33/54), correlated significantly with H. pylori infection in the gastric mucosa. Notably, high CD44v9 expression was significantly associated with low miR-328 expression, whereas low CD44v9 expression was significantly associated with high miR-328 expression.
CONCLUSIONS: We showed that miR-328 downregulation and de novo expression of CD44v9 occurred in H. pylori-infected gastric mucosa adjacent to gastric cancer compared with gastric mucosa not infected with H. pylori adjacent to gastric cancer. CD44v9-overexpressing cells are known to acquire reactive oxygen species resistance; thus, these cells may avoid cell death caused by various stress inducers, which may be linked to the origin of gastric cancer development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25479940     DOI: 10.1007/s00535-014-1019-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

1.  Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies.

Authors:  Hirokazu Yamaguchi; James R Goldenring; Michio Kaminishi; Jeffrey R Lee
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma.

Authors:  Lkhagva-Ochir Tovuu; Satoru Imura; Tohru Utsunomiya; Yuji Morine; Tetsuya Ikemoto; Yusuke Arakawa; Hiroki Mori; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Shuichi Iwahashi; Yu Saito; Shinichiro Yamada; Michihito Asanoma; Hidenori Miyake; Mitsuo Shimada
Journal:  Int J Clin Oncol       Date:  2012-06-16       Impact factor: 3.402

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis.

Authors:  Takatsugu Ishimoto; Hiroko Oshima; Masanobu Oshima; Kazuharu Kai; Ryota Torii; Takashi Masuko; Hideo Baba; Hideyuki Saya; Osamu Nagano
Journal:  Cancer Sci       Date:  2009-12-18       Impact factor: 6.716

5.  Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression.

Authors:  Katrina Gee; Wilfred Lim; Wei Ma; Devki Nandan; Francisco Diaz-Mitoma; Maya Kozlowski; Ashok Kumar
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.

Authors:  Neelakandan Muthukumaran; Karl E Miletti-González; Abhilash K Ravindranath; Lorna Rodríguez-Rodríguez
Journal:  Mol Cancer Res       Date:  2006-08       Impact factor: 5.852

7.  Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.

Authors:  Eri Takahashi; Osamu Nagano; Takatsugu Ishimoto; Toshifumi Yae; Yoshimi Suzuki; Takeshi Shinoda; Satoshi Nakamura; Shinichiro Niwa; Shun Ikeda; Hisashi Koga; Hidenobu Tanihara; Hideyuki Saya
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

8.  Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues.

Authors:  K Higashikawa; H Yokozaki; T Ue; K Taniyama; T Ishikawa; D Tarin; E Tahara
Journal:  Int J Cancer       Date:  1996-03-28       Impact factor: 7.396

9.  Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.

Authors:  Balaji Krishnamachary; Marie-France Penet; Sridhar Nimmagadda; Yelena Mironchik; Venu Raman; Meiyappan Solaiyappan; Gregg L Semenza; Martin G Pomper; Zaver M Bhujwalla
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

10.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

View more
  17 in total

Review 1.  MicroRNA mediated regulation of immunity against gram-negative bacteria.

Authors:  Jonathon Keck; Rishein Gupta; Lane K Christenson; Bernard P Arulanandam
Journal:  Int Rev Immunol       Date:  2017-08-11       Impact factor: 5.311

Review 2.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

Review 3.  Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.

Authors:  Elham Patrad; Solmaz Khalighfard; Taghi Amiriani; Vahid Khori; Ali Mohammad Alizadeh
Journal:  Cell Oncol (Dordr)       Date:  2022-09-23       Impact factor: 7.051

Review 4.  Molecular mechanisms of gastric cancer initiation and progression by Helicobacter pylori.

Authors:  Stephanie L Servetas; Dacie R Bridge; D Scott Merrell
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

Review 5.  Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.

Authors:  Shan-Shan Xie; Juan Jin; Xiao Xu; Wei Zhuo; Tian-Hua Zhou
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 6.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.

Authors:  Fei Ma; Hongjiang Song; Baoliang Guo; Yuxin Zhang; Yasheng Zheng; Chengchun Lin; Ying Wu; Guijie Guan; Ruihua Sha; Qingxin Zhou; Dejun Wang; Xinglu Zhou; Juan Li; Xiaohui Qiu
Journal:  Oncotarget       Date:  2015-07-10

8.  Interplay between Reactive oxygen Species and MicroRNAs in Cancer.

Authors:  Jun He; Bing-Hua Jiang
Journal:  Curr Pharmacol Rep       Date:  2016-02-09

9.  MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma.

Authors:  Xiaoling Luo; Shiyan Yang; Chuanwen Zhou; Feng Pan; Qianjun Li; Shijie Ma
Journal:  Onco Targets Ther       Date:  2015-10-28       Impact factor: 4.147

Review 10.  Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication.

Authors:  Reina Ohba; Katsunori Iijima
Journal:  World J Gastrointest Oncol       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.